Optic Neuritis RENEW Trial Results
The human monoclonal antibody opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.
All articles by Linda Peckel
Comorbidities Significantly Affect Chronic Migraine Health Care Costs
Patients with chronic migraine and comorbidities incur nearly 2 times the health care costs of patients with migraine alone.
Active Medical Device Safety Surveillance
The large number of recalls of medical devices has pointed to a need for more active monitoring of product performance from the standpoints of both safety and efficacy.
A Link Between Altered Reward Processing and Later Pain Complaints?
Reward feedback responses in the brain may be predictive of chronic pain complaints later on.
FDA Guidance on Medical Product Marketing Communication
The FDA released guidance to establish standards for communications about products.
Juvenile Fibromyalgia Pain Treatment Enhanced By Psychosocial Impact Therapies
Novel psychosocial therapies such as cognitive behavioral therapy that have been effective in adults with fibromyalgia need additional neuromuscular fitness training to overcome catastrophizing and fear of exercise in adolescents.
Cognitive Behavioral Therapy as First-Line Therapy for Pediatric Migraine
Cognitive behavioral therapy is an effective nonpharmacologic treatment that should be considered as a first-line therapy for pediatric migraine.
Benefits of Sphenopalatine Ganglion Stimulation for Cluster Headache
Treatment of cluster headache by sphenopalatine ganglion stimulation has long-term benefits in the prevention of attacks.
Effectiveness of Internet-Based CBT Treatment for Insomnia
SHUTi represents “an attractive solution to challenges of scalability.”
Rituximab Shows Promise for Refractory Myasthenia Gravis
Most patients required a least a year to completely withdraw from immunotherapy in order to demonstrate a clinical remission.
-
Loading...
-
Loading...
Next post in Treatments
